Clinical study reveals the high efficacy and well-tolerance of venetoclax combined with homoharringtonine, azacitidine, and cytarabine in newly diagnosed AML
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Xin Yan, Yanqing Huang, Chunhua Song, Zheng Ge
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417020025
Cites:
Cited by:
Related to:
